|
|
Judges Scientific plc
("Judges Scientific")
Total Voting Rights
Judges Scientific confirms that, as at 4 June 2018, the total issued share capital has increased to 6,184,178 ordinary shares of 5p each ("Ordinary Share").
There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,184,178 Ordinary Shares.
The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed.
Ends
Judges Scientific |
|
|
David Cicurel, CEO Brad Ormsby, Group FD |
Tel: +44 (0) 203 829 6970 |
|
Shore Capital (Nominated Adviser & Broker) |
|
|
Stephane Auton Edward Mansfield |
Tel: +44 (0) 20 7408 4090 |
|
Media enquiries: Alma PR (Financial Public Relations) |
|
|
Rebecca Sanders-Hewett John Coles Susie Hudson Sam Modlin
|
Tel: +44 (0) 20 3865 4219 judges@almapr.co.uk |
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 15 businesses acquired since it was first admitted to AIM in 2003.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group holds 5 Queens' awards for innovation and export.
Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.
The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.
For further information, please visit www.judges.uk.com